4.6 Article

Association of visual impairment with risk for future Parkinson's disease

期刊

ECLINICALMEDICINE
卷 42, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.eclinm.2021.101189

关键词

Visual impairment; Parkinson 's disease; Ageing

资金

  1. NHMRC [APP1175405]
  2. Fundamental Research Funds of the State Key Laboratory of Ophthalmology
  3. National Natural Science Foundation of China [82000901, 82101173, 81870663, 82171075]
  4. Outstanding Young Talent Trainee Program of Guangdong Provincial People's Hospital [KJ012019087]
  5. Guangdong Provincial People's Hospital Scien-tific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province [KJ012019457]
  6. Talent Introduction Fund of Guangdong Provincial People's Hospital [Y012018145]
  7. Science and Technology Program of Guangzhou, China [202002020049]
  8. Project of Special Research on Cardiovascular Diseases [2020XXG007]
  9. Research Foundation of Medical Science and Technology of Guangdong Province [B2021237]
  10. University of Melbourne at Research Accelerator Program
  11. CERA Foundation

向作者/读者索取更多资源

The UK Biobank Study found that visual impairment is associated with an increased risk of incident Parkinson's disease, suggesting that visual impairment may be a modifiable risk factor for the prevention of future Parkinson's disease.
Background: Although visual dysfunction is one of the most common non-motor symptoms among patients with Parkinson's disease (PD), it is not known whether visual impairment (VI) predates the onset of clinical PD. Therefore, we aim to examine the association of VI with the future development of PD in the UK Biobank Study. Methods: The UK Biobank Study is one of the largest cohort studies of health, enrolling over 500,000 participants aged 40-69 years between 2006 and 2010 across the UK. VI was defined as a habitual distance visual acuity (VA) worse than 0.3 logarithm of the minimum angle of resolution (LogMAR) in the better-seeing eye. Incident cases of PD were determined by self report data, hospital admission records or death records, whichever came first. Multivariable Cox proportional hazard regression models were used to investigate the association between VI and the risk of incident PD. Findings: A total of 117,050 participants were free of PD at the baseline assessment. During the median observation period of 5.96 (IQR: 5.77-6.23) years, PD occurred in 222 (0.19%) participants. Visually impaired participants were at a higher risk of developing PD than non-VI participants (p < 0.001). Compared with the non-VI group, the adjusted hazard ratio was 2.28 (95% CI 1.29-4.05, p = 0.005) in the VI group. These results were consistent in the sensitivity analysis, where incident PD cases diagnosed within one year after the baseline assessment were excluded. Interpretation: This cohort study found that VI was associated with an increased risk of incident PD, suggesting that VI may serve as a modifiable risk factor for prevention of future PD. Funding: The present work was supported by the NHMRC Investigator Grant (APP1175405), Fundamental Research Funds of the State Key Laboratory of Ophthalmology, National Natural Science Foundation of China (82000901, 82101173, 81870663, 82171075), Outstanding Young Talent Trainee Program of Guangdong Provincial People's Hospital (KJ012019087), Guangdong Provincial People's Hospital Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province (KJ012019457), Talent Introduction Fund of Guangdong Provincial People's Hospital (Y012018145), Science and Technology Program of Guangzhou, China (202002020049), Project of Special Research on Cardiovascular Diseases (2020XXG007), and Research Foundation of Medical Science and Technology of Guangdong Province (B2021237). Prof. Mingguang He receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. (c) 2021 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据